Literature references that cite this PDB file's
key reference
|
 |
| |
PubMed id
|
|
Reference
|
|
|
|
|
|
F.Quintus,
O.Sperandio,
J.Grynberg,
M.Petitjean,
and
P.Tuffery
(2009).
Ligand scaffold hopping combining 3D maximal substructure search and molecular similarity.
|
| |
BMC Bioinformatics, 10,
245.
|
|
|
|
|
|
|
M.Limbach,
A.V.Lygin,
V.S.Korotkov,
M.Es-Sayed,
and
A.de Meijere
(2009).
Facile synthesis of structurally diverse 5-oxopiperazine-2-carboxylates as dipeptide mimics and templates.
|
| |
Org Biomol Chem, 7,
3338-3342.
|
|
|
|
|
|
|
C.Krishnasamy,
A.Raghuraman,
L.B.Kier,
and
U.R.Desai
(2008).
Application of molecular connectivity and electro-topological indices in quantitative structure-activity analysis of pyrazole derivatives as inhibitors of factor xa and thrombin.
|
| |
Chem Biodivers, 5,
2609-2620.
|
|
|
|
|
|
|
N.Singh,
and
J.M.Briggs
(2008).
Molecular dynamics simulations of Factor Xa: insight into conformational transition of its binding subsites.
|
| |
Biopolymers, 89,
1104-1113.
|
|
|
|
|
|
|
Y.N.Imai,
Y.Inoue,
I.Nakanishi,
and
K.Kitaura
(2008).
Cl-pi interactions in protein-ligand complexes.
|
| |
Protein Sci, 17,
1129-1137.
|
|
|
|
|
|
|
C.A.Van Huis,
C.F.Bigge,
A.Casimiro-Garcia,
W.L.Cody,
D.A.Dudley,
K.J.Filipski,
R.J.Heemstra,
J.T.Kohrt,
L.S.Narasimhan,
R.P.Schaum,
E.Zhang,
J.W.Bryant,
S.Haarer,
N.Janiczek,
R.J.Leadley,
T.McClanahan,
J.Thomas Peterson,
K.M.Welch,
and
J.J.Edmunds
(2007).
Structure-based drug design of pyrrolidine-1, 2-dicarboxamides as a novel series of orally bioavailable factor Xa inhibitors.
|
| |
Chem Biol Drug Des, 69,
444-450.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
J.T.Kohrt,
C.F.Bigge,
J.W.Bryant,
A.Casimiro-Garcia,
L.Chi,
W.L.Cody,
T.Dahring,
D.A.Dudley,
K.J.Filipski,
S.Haarer,
R.Heemstra,
N.Janiczek,
L.Narasimhan,
T.McClanahan,
J.T.Peterson,
V.Sahasrabudhe,
R.Schaum,
C.A.Van Huis,
K.M.Welch,
E.Zhang,
R.J.Leadley,
and
J.J.Edmunds
(2007).
The discovery of (2R,4R)-N-(4-chlorophenyl)-N- (2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl)-4-methoxypyrrolidine-1,2-dicarboxamide (PD 0348292), an orally efficacious factor Xa inhibitor.
|
| |
Chem Biol Drug Des, 70,
100-112.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
R.Fasan,
R.L.Dias,
K.Moehle,
O.Zerbe,
D.Obrecht,
P.R.Mittl,
M.G.Grütter,
and
J.A.Robinson
(2006).
Structure-activity studies in a family of beta-hairpin protein epitope mimetic inhibitors of the p53-HDM2 protein-protein interaction.
|
| |
Chembiochem, 7,
515-526.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
K.Schärer,
M.Morgenthaler,
R.Paulini,
U.Obst-Sander,
D.W.Banner,
D.Schlatter,
J.Benz,
M.Stihle,
and
F.Diederich
(2005).
Quantification of cation-pi interactions in protein-ligand complexes: crystal-structure analysis of Factor Xa bound to a quaternary ammonium ion ligand.
|
| |
Angew Chem Int Ed Engl, 44,
4400-4404.
|
|
|
PDB code:
|
|
|
|
|
|
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
234 a.a.
51 a.a.
_CA
